K. Petersson
Molecular Biology · 2022
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 23 citations into it
- Biomaterials — 6 citations into it
- Biomedical Engineering — 6 citations into it
Whom K. Petersson trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Y. Barenholz (in Biomaterials)
Papers from K. Petersson's perspective
Ordered by how strongly the researchers K. Petersson trusts endorse each paper. Same corpus, a different order for every researcher.
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. (Molecular Therapy)
- Pharmacokinetics and biodistribution of nanoparticles. (Molecular Pharmaceutics)
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling (Nature Biotechnology)
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (New England Journal of Medicine)
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. (Molecular Therapy)
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. (Nano letters (Print))
- Mechanism of hard nanomaterial clearance by the liver (Nature Materials)
- Doxil®--the first FDA-approved nano-drug: lessons learned. (Journal of Controlled Release)
- Pharmacokinetics of Pegylated Liposomal Doxorubicin (Clinical Pharmacokinetics)
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines (Molecular Therapy: Nucleic Acids)
Their papers
- The role of lipid components in lipid nanoparticles for vaccines and gene therapy (2022) — 966 citations